Skip to main content
David Hirschman

David Hirschman is an associate in the London office and focuses his practice on corporate and securities matters, with an emphasis on mergers and acquisitions. His experience includes advising on a wide range of corporate and commercial matters for major clients, both in the transactional context and in relation to day-to-day business activities. He is experienced in handling complex cross-border and domestic transactions, investments and reorganizations, advising a range of domestic and international clients from various industries. Having worked in the music industry for a number of years prior to becoming a lawyer, and having spent periods of time working in-house at ITV plc and AstraZeneca plc, he also has substantial business-level experience.

Concentrations

  • Mergers and acquisitions
  • Corporate finance and investments
  • Joint ventures and business reorganisations
  • General corporate and commercial advice
  • Commercial contracts

Capabilities

Experience

  • Represented Black Dragon Capital in connection with its acquisition of Grass Valley, a leading technology supplier of advanced broadcast and media solutions, with operations in over 20 different jurisdictions worldwide.
  • Advised AstraZeneca AB on its agreement with Grünenthal to divest the European rights to Nexium for an upfront payment of $700 million with further sales-related and milestone payments of up to $90 million.
  • Advised AstraZeneca AB on its agreement with Grünenthal to divest the global rights to Vimovo in all markets excluding the US and Japan for an upfront payment of $115 million and further payments up to another $17 million.
  • Advised Abris Capital Partners in relation to shareholder arrangements relating to its acquisition of Velvet CARE sp. z o.o., one of the largest manufacturers of hygiene products in Poland.
  • Advised AstraZeneca plc on the sale of its small molecule antibiotics business to Pfizer for US $1.2 billion.
  • Advised Nomad Foods on its €2.6 billion acquisition of Iglo Foods.
  • Advised Nomad Foods on its €500 million acquisition of Findus Group's Continental European Business.
  • Advised Smiths Group plc on its €140 million divestment of the Wallace product line to CooperSurgical.
  • Advised Gilde Buy Out Partners in the £25 million private equity backed management buyout of the Synbra UK business.°
  • Representation in the $36 million sale of an oil and petroleum marketing and supply group based in Africa to a major global commodities trading and logistics group.°
  • Representation in the dissolution of a joint venture in the defence industry.°
  • Representation in the international expansion of a Bahamas construction operator.°
  • Representation in the winding down of the Forensic Science Service.°
  • Representation of the broker and nomad to AIM listed Fastjet plc in a placing and open offer of shares for £15 million.°
  • Representation of AIM listed Europa Oil and Gas in a cash box placing and open offer of shares for £5 million.°

°The above representations were handled by Mr. Hirschman prior to his joining Greenberg Traurig, LLP.

  • Charles Russell Speechlys LLP, 2010-2015
  • Director and Trustee, Royal Philharmonic Orchestra Limited, 1990-2010

Credentials

Education
  • Legal Practice Course, with distinction, BPP Law School, 2010
  • Graduate Diploma in Law, BPP Law School, 2009
  • Fellow, Trinity College of Music, 1990
Admissions
  • England and Wales